Pivotal bioVenture Partners Fund I, L.P.

Track

Insider profile

Performance

Overall performance
1.3
Performance over holding periods
1.3
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Pivotal bioVenture Partners Fund I, L.P.'s trades of Inozyme Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
278.07
Quantity 1,871 -10.7%
Value US$4,703,997
Transaction date
Purchase
Price
357.81
Quantity 60,069 -38.9%
Value US$4,979,509
Transaction date
Purchase
Price
145.39
Quantity 43,960 +32.4%
Value US$3,114,085
Transaction date
Purchase
Price
16.00
Quantity 187,500 +13.4%
Value US$3,000,000
US Akouos Inc (AKUS)
Transaction date
Purchase
Price
17.00
Quantity 294,117 +19.6%
Value US$4,999,989
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-03 2023-08-01
B Purchase
1,871 -10.7%
278.07
US$4,703,997 		1,871 -10.7% 278.07 US$4,703,997
2023-08-03 2023-08-01
B Purchase
60,069 -38.9%
357.81
US$4,979,509 		60,069 -38.9% 357.81 US$4,979,509
2022-04-20 2022-04-19
B Purchase
43,960 +32.4%
145.39
US$3,114,085 		43,960 +32.4% 145.39 US$3,114,085
2020-07-28 2020-07-28
B Purchase
187,500 +13.4%
16.00
US$3,000,000 		187,500 +13.4% 16.00 US$3,000,000
2020-07-01 2020-06-30
US Akouos Inc (AKUS)
B Purchase
294,117 +19.6%
17.00
US$4,999,989 		294,117 +19.6% 17.00 US$4,999,989